Griffith University has entered into a $135 million commercial partnership with Gene Company o further develop a new drug treatment for SARS-CoV-2, the virus responsible for COVID-19.
Calls for new national clinical guidelines to improve the care of hundreds of thousands of Australians with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), and potentially thousands more with Long Covid.
Griffith University’s research into the potential overlap between Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) has received a major boost thanks to a $6.4 million grant from the Stafford Fox Medical Research Foundation.
Griffith University’s world-first study into cell transplantation to repair injuries to the nervous system has received a major boost thanks to a $5.4 million funding extension from the MAIC.
In a world-first, Griffith University researchers have used an ultra-high field MRI (7 Tesla) to investigate how COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) mirror the same effects on the brain structure.
Bariatric surgery is proving to be an effective treatment for people suffering from type 2 diabetes and morbid obesity, with results showing nearly 50 per cent of patients were able to discontinue all diabetes-related treatment.